Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pediatric Hematology and Oncology|November 24, 2018
Anti TNF-α therapy in patients with relapsed and refractory Langerhans cell histiocytosis: a phase II studyAlejandra Flores Legarreta, Olive Eckstein, Thomas M Burke, et al.
Dermatology Case Reports|June 13, 2020
Thalidomide, A Rational Agent for Treatment of Multicentric ReticulohistiocytosisDaniel J Zinn, Olive Eckstein, Mary L Olsen, et al.
Pediatric Hematology and Oncology|January 1, 2019
Rituximab therapy for patients with Langerhans cell histiocytosis-associated neurologic dysfunctionOlive Eckstein, Casey L McAtee, Jay Greenberg, et al.
Pediatric Blood & Cancer|November 30, 2016
Evaluation of maternal and perinatal characteristics on childhood lymphoma risk: A population-based case-control studyErin C Peckham-Gregory, Heather E Danysh, Austin L Brown, et al.
Pediatric Blood & Cancer|July 25, 2019
Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)Michael B Jordan, Carl E Allen, Jay Greenberg, et al.
British Journal of Haematology|March 19, 2024
Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosisVivekanudeep Karri, Howard Lin, Jessica Velazquez, et al.
Oncotarget|May 18, 2017
Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranulomaRikhia Chakraborty, Oliver A Hampton, Harshal Abhyankar, et al.
Cancer|April 7, 2018
CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesionsKenneth L McClain, Jennifer Picarsic, Rikhia Chakraborty, et al.
Pageof 1